Skip to main content
. 2016 Jul 15;2(2):e000239. doi: 10.1136/rmdopen-2015-000239

Table 1.

Paradoxical conditions described under biological agents given for immune-mediated diseases

True PAE
Borderline PAE
AE Biological agent AE Biological agent
Psoriasis Anti-TNF-α
Rituximab
Tocilizumab
Ustekinumab
Uveitis Anti-TNF-α (etanercept)
Crohn's disease and/or ulcerative colitis Anti-TNF-α (etanercept) Scleritis Anti-TNF-α
Hidradenitis suppurativa Anti-TNF-α
(adalimumab)
Rituximab
Sarcoidosis Anti-TNF-α
(etanercept)
Granuloma annulare Anti-TNF-α
Interstitial granulomatous dermatitis Anti-TNF-α
Vasculitis Anti-TNF-α
Alopecia areata Anti-TNF-α
Vitiligo Anti-TNF-α ustekinumab

AE adverse events; PAE, paradoxical adverse events; TNF, tumour necrosis factor.